CA2454762A1 - Isoxazolopyridinones - Google Patents
Isoxazolopyridinones Download PDFInfo
- Publication number
- CA2454762A1 CA2454762A1 CA002454762A CA2454762A CA2454762A1 CA 2454762 A1 CA2454762 A1 CA 2454762A1 CA 002454762 A CA002454762 A CA 002454762A CA 2454762 A CA2454762 A CA 2454762A CA 2454762 A1 CA2454762 A1 CA 2454762A1
- Authority
- CA
- Canada
- Prior art keywords
- 4alkyl
- phenyl
- compound
- 4alkoxy
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0119911.6A GB0119911D0 (en) | 2001-08-15 | 2001-08-15 | Organic Compounds |
| GB0119911.6 | 2001-08-15 | ||
| PCT/EP2002/009134 WO2003015780A2 (en) | 2001-08-15 | 2002-08-14 | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2454762A1 true CA2454762A1 (en) | 2003-02-27 |
Family
ID=9920454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002454762A Abandoned CA2454762A1 (en) | 2001-08-15 | 2002-08-14 | Isoxazolopyridinones |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7087756B2 (https=) |
| EP (1) | EP1418912B1 (https=) |
| JP (1) | JP2005501847A (https=) |
| KR (1) | KR20040029429A (https=) |
| CN (1) | CN100384418C (https=) |
| AR (1) | AR036351A1 (https=) |
| AT (1) | ATE355059T1 (https=) |
| BR (1) | BR0211903A (https=) |
| CA (1) | CA2454762A1 (https=) |
| CO (1) | CO5560566A2 (https=) |
| DE (1) | DE60218484T2 (https=) |
| EC (1) | ECSP044971A (https=) |
| ES (1) | ES2282467T3 (https=) |
| GB (1) | GB0119911D0 (https=) |
| HU (1) | HUP0401325A3 (https=) |
| IL (1) | IL160018A0 (https=) |
| MX (1) | MXPA04001419A (https=) |
| NO (1) | NO20040659L (https=) |
| PE (1) | PE20030356A1 (https=) |
| PL (1) | PL366848A1 (https=) |
| PT (1) | PT1418912E (https=) |
| RU (1) | RU2004107847A (https=) |
| WO (1) | WO2003015780A2 (https=) |
| ZA (1) | ZA200400525B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2451057A1 (en) * | 2001-06-14 | 2002-12-27 | Banyu Pharmaceutical Co., Ltd. | Novel isoxazolopyridone derivatives and use thereof |
| BRPI0511099A (pt) * | 2004-05-14 | 2007-12-26 | Irm Llc | compostos e composições como moduladores de ppar |
| RU2008135762A (ru) * | 2006-02-16 | 2010-03-27 | Де МакЛин Хоспитал Корпорейшн (US) | Способы и композиции для лечения болезни паркинсона |
| US7666888B2 (en) | 2006-07-20 | 2010-02-23 | Amgen Inc. | Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 |
| FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
| FR2933609B1 (fr) * | 2008-07-10 | 2010-08-27 | Fournier Lab Sa | Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson. |
| CA2749585A1 (en) | 2009-01-13 | 2010-07-22 | Van Andel Research Institute | Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| FR2950053B1 (fr) | 2009-09-11 | 2014-08-01 | Fournier Lab Sa | Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson |
| FR2955110A1 (fr) | 2010-01-08 | 2011-07-15 | Fournier Lab Sa | Nouveaux derives de type pyrrolopyridine benzoique |
| DE102011085038A1 (de) | 2011-10-21 | 2013-04-25 | Tesa Se | Verfahren zur Kapselung einer elektronischen Anordnung |
| JP2016531852A (ja) | 2013-09-25 | 2016-10-13 | ヴァン アンデル リサーチ インスティテュート | 非常に強力なグルココルチコイド |
| KR20170033630A (ko) | 2015-09-17 | 2017-03-27 | (주)다올 | 도로용 경계블럭 |
| CN110382033B (zh) | 2016-10-14 | 2022-04-15 | 范安德尔研究所 | 用于设计高效力糖皮质激素的结构与机制 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7602542L (sv) | 1975-03-14 | 1976-09-15 | Sandoz Ag | 3-(alfa-iminobensyl)-4-hydroxi-2(lh)-pyridoner |
| US4064251A (en) | 1976-06-25 | 1977-12-20 | Sandoz, Inc. | Substituted hydroxy pyridones |
| US4049813A (en) * | 1976-07-15 | 1977-09-20 | Sandoz, Inc. | Substituted isoxazolo pyridinones |
| DE2801190A1 (de) | 1977-01-19 | 1978-07-20 | Sandoz Ag | 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat |
| US4238616A (en) | 1977-01-19 | 1980-12-09 | Sandoz, Inc. | 3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides |
| US4113727A (en) * | 1977-04-26 | 1978-09-12 | Sandoz, Inc. | Process for the preparation of substituted isoxazolo[4,5-c]pyridin-4-(5H)-ones |
| CA2451057A1 (en) * | 2001-06-14 | 2002-12-27 | Banyu Pharmaceutical Co., Ltd. | Novel isoxazolopyridone derivatives and use thereof |
-
2001
- 2001-08-15 GB GBGB0119911.6A patent/GB0119911D0/en not_active Ceased
-
2002
- 2002-08-13 AR ARP020103046A patent/AR036351A1/es unknown
- 2002-08-14 JP JP2003520739A patent/JP2005501847A/ja not_active Withdrawn
- 2002-08-14 EP EP02772157A patent/EP1418912B1/en not_active Expired - Lifetime
- 2002-08-14 RU RU2004107847/15A patent/RU2004107847A/ru not_active Application Discontinuation
- 2002-08-14 IL IL16001802A patent/IL160018A0/xx unknown
- 2002-08-14 DE DE60218484T patent/DE60218484T2/de not_active Expired - Lifetime
- 2002-08-14 ES ES02772157T patent/ES2282467T3/es not_active Expired - Lifetime
- 2002-08-14 HU HU0401325A patent/HUP0401325A3/hu unknown
- 2002-08-14 KR KR10-2004-7002124A patent/KR20040029429A/ko not_active Ceased
- 2002-08-14 AT AT02772157T patent/ATE355059T1/de not_active IP Right Cessation
- 2002-08-14 PT PT02772157T patent/PT1418912E/pt unknown
- 2002-08-14 BR BR0211903-0A patent/BR0211903A/pt not_active IP Right Cessation
- 2002-08-14 MX MXPA04001419A patent/MXPA04001419A/es unknown
- 2002-08-14 CA CA002454762A patent/CA2454762A1/en not_active Abandoned
- 2002-08-14 PL PL02366848A patent/PL366848A1/xx not_active Application Discontinuation
- 2002-08-14 PE PE2002000734A patent/PE20030356A1/es not_active Application Discontinuation
- 2002-08-14 CN CNB028159268A patent/CN100384418C/zh not_active Expired - Fee Related
- 2002-08-14 WO PCT/EP2002/009134 patent/WO2003015780A2/en not_active Ceased
- 2002-08-14 US US10/486,569 patent/US7087756B2/en not_active Expired - Fee Related
-
2004
- 2004-01-23 ZA ZA200400525A patent/ZA200400525B/en unknown
- 2004-02-03 EC EC2004004971A patent/ECSP044971A/es unknown
- 2004-02-13 NO NO20040659A patent/NO20040659L/no not_active Application Discontinuation
- 2004-03-12 CO CO04023011A patent/CO5560566A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003015780A8 (en) | 2004-05-21 |
| MXPA04001419A (es) | 2004-05-27 |
| US20040248893A1 (en) | 2004-12-09 |
| CO5560566A2 (es) | 2005-09-30 |
| JP2005501847A (ja) | 2005-01-20 |
| WO2003015780A2 (en) | 2003-02-27 |
| ATE355059T1 (de) | 2006-03-15 |
| CN1635889A (zh) | 2005-07-06 |
| RU2004107847A (ru) | 2005-05-10 |
| ECSP044971A (es) | 2004-03-23 |
| DE60218484D1 (de) | 2007-04-12 |
| ES2282467T3 (es) | 2007-10-16 |
| PE20030356A1 (es) | 2003-05-14 |
| EP1418912B1 (en) | 2007-02-28 |
| US7087756B2 (en) | 2006-08-08 |
| BR0211903A (pt) | 2004-09-21 |
| HUP0401325A3 (en) | 2005-09-28 |
| HUP0401325A2 (hu) | 2004-10-28 |
| NO20040659D0 (no) | 2004-02-13 |
| DE60218484T2 (de) | 2007-11-15 |
| WO2003015780A3 (en) | 2003-11-13 |
| EP1418912A2 (en) | 2004-05-19 |
| KR20040029429A (ko) | 2004-04-06 |
| NO20040659L (no) | 2004-02-13 |
| CN100384418C (zh) | 2008-04-30 |
| PL366848A1 (en) | 2005-02-07 |
| ZA200400525B (en) | 2005-04-01 |
| IL160018A0 (en) | 2004-06-20 |
| AR036351A1 (es) | 2004-09-01 |
| PT1418912E (pt) | 2007-05-31 |
| GB0119911D0 (en) | 2001-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1325501C (zh) | 杂环化合物 | |
| CN106661002B (zh) | 用于治疗炎性、代谢性、肿瘤性和自身免疫性疾病的嘧啶衍生物 | |
| AU2004212151B2 (en) | Heterocyclic compounds useful as Nurr-1 activators | |
| US7087756B2 (en) | Isoxazolopyridinones | |
| TW201206944A (en) | Morpholine compounds | |
| SG185484A1 (en) | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes | |
| JP2004524317A (ja) | アンドロゲン受容体モジュレーター化合物としての三環式キノリノンおよび三環式キノリン | |
| TW200804378A (en) | Organic compounds | |
| CN1042225C (zh) | 新的取代的异噁唑衍生物的制备方法 | |
| WO2020156479A1 (zh) | 环丙烯并苯并呋喃取代的氮杂芳基化合物、其中间体、制备方法及应用 | |
| JP2022523668A (ja) | Ｍａｇｌ阻害剤による疾病の治療方法 | |
| CN114656472B (zh) | 吡唑并嘧啶类化合物、异构体或盐及其制备方法和用途 | |
| DK2546255T3 (en) | benzazepine | |
| WO2015186061A1 (en) | Pyridopyrimidinedione derivatives | |
| TW201016698A (en) | Antiviral compounds | |
| CN114891003A (zh) | 新型二氢嘧啶类化合物、中间体或盐及其制备方法和用途 | |
| CN112759588B (zh) | 苯并五元杂环胺类衍生物及其用途 | |
| MXPA04007738A (es) | 2-oxazolaminas y su uso como antagonistas del receptor 5-ht2b. | |
| AU2002336977A1 (en) | Isoxazolopyridinones and use thereof in the treatment of Parkinson's disease | |
| WO2018206820A1 (en) | Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors | |
| CN103906751A (zh) | 作为晚期SV40因子（LSF）抑制剂用于治疗癌症的[1,3]二氧杂环戊烯并[4,5-g]喹啉-6(5H)-硫酮和[1,3]二氧杂环戊烯并[4,5-g][1,2,4]三唑并[1,5-a]喹啉衍生物 | |
| CN115611877A (zh) | 磺酰胺类化合物、其制备方法及其在医药上的应用 | |
| CN114656480B (zh) | 噻吩并嘧啶类化合物、异构体或盐及其制备方法和用途 | |
| WO2005016255A2 (en) | Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds | |
| CN114671876B (zh) | 新型茶碱类化合物、异构体或盐及其制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |